1.
Kristin E, Endarti D, Febrinasari RP, Nugrahaningsih DAA, Pratiwi WR. Budget Impact Analysis of Sacubitril Valsartan in the Treatment of Heart Failure and Reduced Ejection Fraction (HFrEF) in Indonesia. Indonesian J Pharm [Internet]. 2022Feb.8 [cited 2024Jun.24];33(1):83-2. Available from: https://jurnal.ugm.ac.id/v3/IJP/article/view/2529